ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland (HepCOP)

This study has been completed.

Sponsors and Collaborators: Seidenberg, Arztpraxis A., M.D.
University of Zurich
Information provided by: Seidenberg, Arztpraxis A., M.D.
ClinicalTrials.gov Identifier: NCT00473993
  Purpose

Hepatitis C viral infection is common among opioid addicts in Zurich, Switzerland. The majority undergoes a maintenance treatment with methadone, heroin or buprenorphine. While stabilized by an opioid maintenance treatment (OMT)chronic hepatitis C can be treated with pegylated interferon plus ribavirin. As not sufficiently known, the results are comparable to the results of the treatment of nonaddicts.

Our crossectional study investigates how many patients undergoing OMT are adequately investigated concerning hepatitis C. If not, why are they not adequately investigated and treated? Representative data are collected in the local clinics and medical practices involved in OMT in the Kanton of Zurich. The patients files are revised and the involved doctors are asked through a structured interview.


Condition
Hepatitis C, Chronic
Substance Abuse Treatment Centers
Opioid-Related Disorders

MedlinePlus related topics:   Hepatitis    Hepatitis C   

ChemIDplus related topics:   Methadone    Methadone hydrochloride    Interferon alfa-2b    Interferons    Buprenorphine    Buprenorphine hydrochloride    Diacetylmorphine    Diacetylmorphine hydrochloride   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Retrospective
Official Title:   Hepatitis C Bei Opioidabhängigen in Der Praxis, Eine Querschnittsuntersuchung

Further study details as provided by Seidenberg, Arztpraxis A., M.D.:

Study Start Date:   July 2007
Study Completion Date:   December 2007

Detailed Description:

www.seidenberg.ch/hepcop.pdf

  Eligibility
Genders Eligible for Study:   Both

Study Population

Patients in opioid maintenance treatment in the kanton of Zurich, Switzerland


Criteria

Inclusion Criteria:

  • Medical practices and clinics involved in opioid maintenance treatment in the Kanton of Zurich, Switzerland
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00473993

Sponsors and Collaborators
Seidenberg, Arztpraxis A., M.D.
University of Zurich

Investigators
Study Director:     André Seidenberg, Dr.med.     research fellow EHAM, University of Zurich    
  More Information

download of the protocol of the HepCOP-study  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   HepCOP Zurich
First Received:   May 15, 2007
Last Updated:   April 25, 2008
ClinicalTrials.gov Identifier:   NCT00473993
Health Authority:   Switzerland: Ethikkommision

Keywords provided by Seidenberg, Arztpraxis A., M.D.:
Hepatitis C  
Opioid Maintenance Treatment  
Methadone  
Buprenorphine
Heroin
Interferon, pegylated

Study placed in the following topic categories:
Liver Diseases
Hepatitis, Chronic
Heroin
Interferons
Hepatitis, Viral, Human
Disorders of Environmental Origin
Opioid-Related Disorders
Hepatitis
Virus Diseases
Methadone
Buprenorphine
Digestive System Diseases
Mental Disorders
Substance-Related Disorders
Hepatitis C
Hepatitis C, Chronic
Interferon Alfa-2b

Additional relevant MeSH terms:
RNA Virus Infections
Flaviviridae Infections

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers